Compositions comprising magnolia, phellodendron, theanine and/or whey protein
AssigneeNutramax Laboratories, Inc.
InventorsTodd Henderson, David Griffin, David Bledsoe
Life of this patent
Estimating the term…
Abstract
An anxiolytic composition includes a synergistic combination of one or more of an extract of magnolia, an extract of phellodendron, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe).
Claims28
An anxiolytic composition, comprising a synergistic combination of L-theanine and a whey protein.
A method for reducing, ameliorating, or treating symptoms of anxiety, comprising administration of a synergistic combination of L-theanine and a whey protein to a mammal.
An anxiolytic composition, comprising a synergistic combination of L-theanine and s-adenosylmethionine (SAMe).
A method for reducing, ameliorating, or treating symptoms of anxiety, comprising administration of a synergistic combination of L-theanine and s-adenosylmethionine (SAMe) to a mammal.
An anxiolytic composition, comprising a synergistic combination of from about 17.0 to about 450 mg of L-theanine, from about 12.0 to about 100 mg of alpha-lactalbumin, from about 0.5 to about 3 mg of an extract of magnolia, and from about 0.03 to about 0.2 mg of an extract of phellodendron.
An anxiolytic composition, comprising a synergistic combination of from about 0.01 mg to about 10 g of L-theanine, from about 0.01 mg to about 10 g of alpha-lactalbumin, from about 0.01 mg to about 10 g of an extract of magnolia, and from about 0.01 mg to about 10 g mg of an extract of phellodendron.
Dependencies are inferred from the claim text.